Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

CHICAGO -- Patients with advanced prostate cancer treated with enzalutamide (Xtandi) had a significantly greater decline in ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

A simple blood test could prevent many prostate cancer deaths, according to a review by Cochrane. Early detection through a ...

Researchers have found a simple at home urine test for prostate cancer screening is highly accurate. Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine ...

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States. To confirm the diagnosis, biopsies are required. A team of researchers has now ...

The cognitive effects men with advanced prostate cancer experience during treatment may vary based on the therapy they ...

Prostate health remains a crucial topic that many men avoid discussing, even with close family members. Early screenings can make a significant difference in detecting issues before they become severe ...

Treatment options for prostate cancer have dramatically expanded. Facing a prostate cancer diagnosis often raises concerns among men and their partners: will treatment affect intimacy and their ...

A comprehensive study reveals prostate cancer screening saves lives, reducing deaths by two per 1,000 men screened, but many ...